血栓与出血

Thrombosis and bleeding

经皮冠状动脉介入治疗与抗栓药物在显著降低急性冠状动脉综合征患者缺血事件的同时,也相应增加了出血风险。出血发生率增高与患者不良临床预后强烈相关。全面评估患者出血风险进行危险分层,谨慎平衡缺血与出血风险制定治疗策略,预防控制出血并发症,在临床实践中非常重要。

Percutaneous coronary intervention and antithrombotic therapy have resulted in significant improvement in reducing ischemic events in acute coronary syndrome（ACS）, at the same time leading to an increase in the risk of bleeding. There has been increasing data demonstrating that bleeding has a strong association with subsequent adverse outcomes. Therefore, it is imperative to optimize patient outcomes by performing bleeding risk assessment and stratification, adopting pharmacological and nonpharmacological strategies to minimize bleeding while maximizing treatment efficacy.